Literature DB >> 9868656

Epidemiological and clinical aspects of invasive group A streptococcal infections and the streptococcal toxic shock syndrome.

B K Eriksson1, J Andersson, S E Holm, M Norgren.   

Abstract

In a retrospective study of invasive infections due to group A Streptococcus (GAS) in Stockholm during 1987 to 1995, the average incidence per 100,000 residents per year was 2.3, varying between 3.7 per 100,000 (in 1988) and 1.3 per 100,000 (in 1993). Incidence was 1.8 in the age group of 0-4 years but otherwise increased by age, from 0.48 in the age group of 5-14 years to 6.1 among those over 65 years of age. A review of 151 invasive episodes occurring in 1983-1995 showed cyclic increases of infections due to T1M1-serotype strains during 1986-1990 and 1993-1995. The T1M1 serotype accounted for 27 (20%) of 135 available GAS strains. Streptococcal toxic shock syndrome (STSS) developed in 19 (13%) of the 151 episodes. The case fatality rate was 11% overall but 47% among patients with STSS. In a multivariate logistic regression model, STSS was associated with a history of alcohol abuse (odds ratio [OR], 6.3; P = .004) and infection with a T1M1 strain (OR, 6.7; P = .007). Case fatality was associated with age (OR, 14.5; P = .08), immunosuppression (OR, 4.7; P = .02), and STSS (OR, 21.5; P < .0001) but not with T1M1 infection. Hypotension was significantly associated with a fatal outcome, regardless of whether STSS developed (P < .0001).

Entities:  

Mesh:

Year:  1998        PMID: 9868656     DOI: 10.1086/515012

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  25 in total

1.  Growth-phase-dependent expression of virulence factors in an M1T1 clinical isolate of Streptococcus pyogenes.

Authors:  M Unnikrishnan; J Cohen; S Sriskandan
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

2.  Therapeutic Approaches to Streptococcal Toxic Shock Syndrome.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-08       Impact factor: 3.725

3.  Variations in emm type among group A streptococcal isolates causing invasive or noninvasive infections in a nationwide study.

Authors:  Kim Ekelund; Jessica Darenberg; Anna Norrby-Teglund; Steen Hoffmann; Didi Bang; Peter Skinhøj; Helle Bossen Konradsen
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

4.  Evolving epidemiologic characteristics of invasive group a streptococcal disease in Utah, 2002-2010.

Authors:  Chris Stockmann; Krow Ampofo; Adam L Hersh; Anne J Blaschke; Brian A Kendall; Kent Korgenski; Judy Daly; Harry R Hill; Carrie L Byington; Andrew T Pavia
Journal:  Clin Infect Dis       Date:  2012-04-24       Impact factor: 9.079

5.  Reemergence of emm1 and a changed superantigen profile for group A streptococci causing invasive infections: results from a nationwide study.

Authors:  Kim Ekelund; Peter Skinhøj; Jesper Madsen; Helle Bossen Konradsen
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

6.  Streptococcal DNase B is immunologically identical to superantigen SpeF but involves separate domains.

Authors:  A Eriksson; B Eriksson; S E Holm; M Norgren
Journal:  Clin Diagn Lab Immunol       Date:  1999-01

7.  Endogenous interleukin-6 plays a crucial protective role in streptococcal toxic shock syndrome via suppression of tumor necrosis factor alpha production.

Authors:  Hongyan Diao; Masashi Kohanawa
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

8.  Do cardiomyocytes mount an immune response to Group A Streptococcus?

Authors:  Zhi Li; Amy E Bryant; Stephanie M Hamilton; Clifford R Bayer; Yongsheng Ma; Dennis L Stevens
Journal:  Cytokine       Date:  2011-03-04       Impact factor: 3.861

9.  emm1/sequence type 28 strains of group A streptococci that express covR at early stationary phase are associated with increased growth and earlier SpeB secretion.

Authors:  Chuan Chiang-Ni; Po-Xing Zheng; Yueh-Ren Ho; Hsiu-Mei Wu; Woei-Jer Chuang; Yee-Shin Lin; Ming-T Lin; Ching-Chuan Liu; Jiunn-Jong Wu
Journal:  J Clin Microbiol       Date:  2009-08-26       Impact factor: 5.948

10.  Prospective surveillance of invasive group a streptococcal disease, Fiji, 2005-2007.

Authors:  Andrew C Steer; Adam Jenney; Joseph Kado; Michael F Good; Michael Batzloff; Lepani Waqatakirewa; E Kim Mullholland; Jonathan R Carapetis
Journal:  Emerg Infect Dis       Date:  2009-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.